Protective Effects of Galangin Against Cyclophosphamide‐Induced Cardiotoxicity via Suppressing NF‐κB and Improving Mitochondrial Biogenesis
- 25 February 2025
- journal article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (3) , e70193
Abstract
Cyclophosphamide (CYP) is an effective chemotherapeutic and immunosuppressive agent; however, its clinical application is limited by a variety of toxic side effects. Mitochondrial dysfunction has been associated with the pathogenesis of chemotherapy‐induced cardiotoxicity. This work aimed to evaluate the possible protective effect of galangin (Gal) on CYP‐induced cardiotoxicity, pointing to its ability to promote mitochondrial biogenesis. Thirty two male rats were allocated equally into four groups: control; Gal‐treated; CYP‐treated; and Gal + CYP‐treated groups. Markers of cardiac injury, oxidative/antioxidant status, inflammation, apoptosis, and mitochondrial function were assessed in addition to histopathological and electrocardiographic (ECG) evaluation. The current results revealed that Gal treatment significantly attenuated the cardiac injury and retrieved the alterations in cardiac histopathology and ECG changes. Also, it restored redox balance, as evidenced by the alleviation of malondialdehyde (MDA) levels and increased glutathione peroxidase (GPx) activity. Gal activated the sirtuin (SIRT) 1/nuclear factor erythroid 2‐related factor 2 (Nrf2)‐mediated signaling pathway, as indicated by upregulation of SIRT1, Nrf2, SIRT3, and mitochondrial transcription factor (TFAM), in addition to increased levels of superoxide dismutase 2 (SOD)2 and peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), together with increased activity of citrate synthase (CS), pointing to improved mitochondrial function. It ameliorated the inflammation and apoptosis‐associated markers supported by biochemical and immunostaining data. Our study provided novel insights elucidating the mitigative potential of against CYP‐induced cardiac oxidative damage, inflammation, apoptosis, and mitochondrial dysfunction by upregulating the SIRT1/Nrf2/SIRT3/PGC‐1α/TFAM survival pathway.Keywords
This publication has 59 references indexed in Scilit:
- Oxygen–Glucose Deprivation/Reperfusion-Induced Sirt3 Reduction Facilitated Neuronal Injuries in an Apoptosis-Dependent Manner During Prolonged ReperfusionNeurochemical Research, 2022
- The modulation of SIRT1 and SIRT3 by natural compounds as a therapeutic target in doxorubicin‐induced cardiotoxicity: A reviewJournal of Biochemical and Molecular Toxicology, 2021
- Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced CardiotoxicityCardiovascular Toxicology, 2019
- Galangin ameliorates cardiac remodeling via the MEK1/2–ERK1/2 and PI3K–AKT pathwaysJournal of Cellular Physiology, 2019
- Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridineJournal of Molecular Modeling, 2018
- Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitateCancer Chemotherapy and Pharmacology, 2017
- Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in RatsBiological Trace Element Research, 2016
- Soy isoflavone attenuates brain mitochondrial oxidative stress induced by beta‐amyloid peptides 1–42 injection in lateral cerebral ventricleJournal of Neuroscience Research, 2012
- Immunohistochemistry: Basics and Methods2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001